Tech from Isansys Lifecare is being used in a ground-breaking health study in Germany.
The Oxford-headquartered firm was second on our MedTech 50 ranking this year,
Its Patient Status Engine is a remote patient monitoring platform combining wearable sensors, wireless connectivity, predictive AI analytics, dashboards and alerting for hospital, home and community settings.
Isansys Lifecare – Every patient monitored, connected and safe
Patients from the town of Attendorn are being prescribed vital data monitoring as part of a study into how telemedicine can support healthcare to tackle the challenge of rural ambulatory care in the future in the context of changing demographics and staff shortages.
The Telemed@ATN study is currently in its testing phase, with 20 patients engaging in remote vital data monitoring from the comfort of their homes.
The research, approved by the ethics committee of Witten/Herdecke University, is a crucial initiative in the context of data medicine to assess the impact of digital and telemedical approaches on healthcare in Attendorn. The carefully selected participants, split equally between two medical practices – Laufenberg & Schulze MD and Rustemeyer & Falke MD – are prescribed vital data monitoring as part of the research project.
https://businesscloud.co.uk/medtech-50-uks-most-innovative-medical-technology-creators/
The town of Attendorn is co-funding the study with the aim to help reduce the workload of medical staff in local doctor’s offices and maintain high-quality healthcare services. The project lead and scientific supervision for evaluation is conducted by the Digitale Modellregion Gesundheit Dreiländereck (DMGD), Siegen University.
Before the commencement of vital data monitoring, Prof Nabeel Farhan, MD, conducted individual interviews with patients to ensure a personalised approach to their healthcare needs. The primary objective is not only to enhance general practitioner care but also to evaluate the seamless transmission of data and patient comfort during the monitoring period.
All participants received a tablet for vital data monitoring. Depending on their prescription, participants took home a cardio patch, a pulse oximeter, and/or a blood pressure monitor, all provided by Isansys Lifecare Europe GmbH for the duration of the test.
The devices, approved as medical devices, facilitate the automatic transfer of vital data to the tablet, which is then transmitted to the relevant GP practice via an app. This seamless data transfer enables quick recognition of abnormalities, contributing to more effective patient care.
Keith Errey, co-founder and CEO of Isansys, said: “We are excited to be part of this ground-breaking project that showcases the potential of remote patient monitoring in advancing healthcare for patients in any setting. The Patient Status Engine is designed to provide real-time, actionable insights, and its role in this study underscores its capability to contribute to the future of healthcare delivery.”
Participants will provide insights into the test process through questionnaires, with feedback from the medical practices also considered in the analysis.